12-time Olympic Medalist Issued Doping Ban Thanks To Instagram

12-time Olympic Medalist Issued Doping Ban Thanks To Instagram
Maurice Brosnan
By Maurice Brosnan
Share this article

Ryan Lochte has been handed a 14-month doping ban from the United States Anti-Doping Agency (USADA) for the use of intravenous infusions. The American swimmer has accepted the suspension.

Lochte was outed after he published a picture on Instagram of himself and his wife receiving the treatment. While the substance is legal, it is banned by the World Anti-Doping Agency without a Therapeutic Use Exemption (TUE). Lofte cooperated fully with the investigation.

Recommended

His ban began on May 24, 2018, the day he attended the infusion clinic.

USADA released a statement confirming the new today.

Ryan Lochte has accepted a 14-month sanction for his use of a prohibited method. On May 24, Lochte posted an image on social media depicting himself receiving an intravenous infusion.

A subsequent investigation by USADA, with which Lochte fully co-operated, revealed that Lochte received an intravenous infusion of permitted substances at an infusion clinic in a volume greater than 100ml in a 12-hour period without a therapeutic use exemption.

The 33-year-old is a 12-time Olympic medalist and second in swimming behind fellow American Michael Phelps. He has previously served a 10-month ban due to an incident at the Olympics in 2016. After a drunken night out, Lofte created a fake story to cover for his involvement in vandalising a gas station.

Advertisement
Ryan Lochte

Lochte had been training towards making the US Olympic team in 2020. As part of that, he was set to race next week at the Nationals but this is no longer possible.

Join The Monday Club Have a tip or something brilliant you wanted to share on? We're looking for loyal Balls readers free-to-join members club where top tipsters can win prizes and Balls merchandise

Processing your request...

You are now subscribed!

Share this article

Copyright © 2024. All rights reserved. Developed by Square1 and powered by PublisherPlus.com

Advertisement